Editas Medicine(DE:8EM)
€2.42+0.14 (+7.08%)
DE:8EM
Editas Medicine earnings date
€2.42
At close:+0.14 (+7.08%)
Editas Medicine (8EM) Q2 2023 Earnings Report
2 Followers
DE:8EM Q2 2023 EPS Results
- Actual EPS
- -EUR 0.50
- Consensus EPS
- -EUR 0.69
- Beat/Miss
- Beat by +EUR 0.19
- One Year Ago EPS
- -EUR 0.70
DE:8EM Q2 2023 Revenue Results
- Actual Revenue
- EUR 2.58M
- Expected Revenue
- EUR 3.74M
- Beat/Miss
- Missed by -EUR 1.15M
- YoY Revenue Growth
- -54.62%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/02/2023
- Time
- Before Open
- Conference Call
- Wednesday, August 2, 2023
DE:8EM Upcoming Earnings
Editas Medicine's next earnings date is estimated for February 25, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
DE:8EM Q2 2023 Earnings Call
0:00 / 0:00
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:8EM Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 25, 2027 | 2026 (Q4) | -0.16- | -0.05 | ― | ― |
| Nov 09, 2026 | 2026 (Q3) | -0.17-0.13 | -0.25 | 46.43% (+0.12) | |
| Aug 05, 2026 | 2026 (Q2) | -0.24-0.13 | -0.56 | 76.19% (+0.43) | |
| May 05, 2026 | 2026 (Q1) | -0.24-0.23 | -0.82 | 71.74% (+0.59) | |
| Mar 09, 2026 | 2025 (Q4) | -0.21-0.05 | -0.49 | 89.09% (+0.44) | |
| Nov 10, 2025 | 2025 (Q3) | -0.27-0.25 | -0.67 | 62.67% (+0.42) | |
| Aug 12, 2025 | 2025 (Q2) | -0.35-0.56 | -0.73 | 23.17% (+0.17) | |
| May 12, 2025 | 2025 (Q1) | -0.50-0.82 | -0.68 | -21.05% (-0.14) | |
| Mar 05, 2025 | 2024 (Q4) | -0.34-0.49 | -0.21 | -139.13% (-0.29) | |
| Nov 04, 2024 | 2024 (Q3) | -0.67-0.67 | -0.49 | -36.36% (-0.18) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
